Two network meta-analyses indirectly compared data retrieved from the above-mentioned RCTs and reported no significant differences among patients with NSCLC without PD-L1 selection between NICT and PCT in overall survival (OS) and AEs ≥ grade 3 [8, 9]. The gene discussed is CD274; the disease is non-small cell lung carcinoma.